"Navigating the Modern News Zoo so you don't have to."
Tuesday, March 25, 2025
Improving GLP-1 drug delivery by 'painting' it on antibodies
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have made it difficult for people to start and maintain treatment.
đ Full Story
Rosie O'Donnell fled America to escape Donald Trump
- ESA launches a major accessibility initiative at GDC - Dean Takahashi
- Google says a technical issue caused some usersâ Maps Timeline data to be deleted - Cheyenne MacDonald
- Piers Morgan, Panel Burst Into Laughter After âPBDâ Host Unveils Before And After âTrump Derangementâ Photos - Hailey Gomez
- Apple Music integration is now available on more DJ platforms - Billy Steele
- Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
- How Enterprise Failed And Doomed Star Trek - Joshua Tyler
Best-est Holi Gadget Ever!
- Nvidia announces DGX desktop âpersonal AI supercomputersâ - Benj Edwards
- Battlestar Galactica Nearly Ruined Entire Show With Canceled Season 1 Story - Chris Snellgrove
- Trump Plans to Move Student Loan Portfolio to SBA. Hereâs What Borrowers Need to Know
- Bern-ing Biden: 'Nobody Thinks Illegal Immigration Is Appropriate'
- Make Money Walking: 10 Best Apps That Pay You To Walk - Robina Anwar
- Security teams can respond 80% faster to events with Cyberhavenâs AI-powered data lineage tools - Taryn Plumb
